CoChat

Tumor-Infiltrating Lymphocyte Function Predicts Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer

Open access
Kong, Joseph Cherng Huei, Guerra, Glen Robert, Millen, Rosemary Magdalena, Roth, Sara, Xu, Huiling, Neeson, Paul Joseph, Darcy, Phillip Kevin, Kershaw, Michael Henry, Sampurno, Shienny, Malaterre, Jordane, Liu, David Shi Hao, Pham, Toan Duc, Narasimhan, Vignesh, Wang, Minyu, Huang, Yu-Kuan, Visvanathan, Kumar, McCormick, Jacob, Lynch, Andrew Craig, Warrier, Satish, Michael, Michael, Desai, Jayesh, Murray, William, Mitchell, Catherine, Ngan, Samuel, Phillips, Wayne Allen, Heriot, Alexander Graham, Ramsay, Robert George · 2018 · JCO Precision Oncology
Cited by 96

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

Purpose: The presence of tumor-infiltrating lymphocytes (TILs) in tumors is superior to conventional pathologic staging in predicting patient outcome. However, their presence does not define TIL functionality. Here we developed an assay that tests TIL cytotoxicity in patients with locally advanced rectal cancer before definitive treatment, identifying those who will obtain a pathologic complete response (pCR). We also used the assay to demonstrate the rescue of TIL function after checkpoint inhibition blockade (CIB). Patients and Methods: Thirty-four consecutive patients were identified initially, with successful completion of the assay before surgery in those 17 patients who underwent full treatment. An in vitro cytotoxic assay of rectal cancer tumoroids cocultured with patient-matched TILs was established and validated. Newly diagnosed patients were recruited with pretreatment biopsy specimens processed within 1 month. Evaluation of TIL-mediated tumoroid lysis was performed by measuring the mean fluorescence intensity of cell death marker, propidium iodide. CIB (anti–programmed cell death protein 1 [anti–PD-1] antibody) response was also assessed in a subset of patient specimens. Results: Six of the 17 patients achieved an objective pCR on final evaluation of the resected specimen after neoadjuvant chemoradiotherapy. Cytotoxic killing identified the pCR group with a higher mean fluorescence intensity (27,982 [95% CI, 25,340 to 30,625]) compared with the non-pCR cohort (12,428 [95% CI, 9,434 to 15,423]; p < .001). Assessment of the effectiveness of CIB revealed partial restoration of cytotoxicity in TILs with increased PD-1 expression with anti–PD-1 antibody exposure. Conclusion: Evaluating TIL function can be undertaken within weeks of the diagnostic biopsy, affording the potential to alter patient management decisions and refine selection for a watch-and-wait protocol. This cytotoxic assay also has the potential to serve as a platform to assist in the additional development of CIB.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1200/po.18.00075

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Cited by

See all 96

Metadata

Authors
Kong, J. C. H., Guerra, G. R., Millen, R. M., Roth, S., Xu, H., Neeson, P. J., Darcy, P. K., Kershaw, M. H., Sampurno, S., Malaterre, J., Liu, D. S. H., Pham, T. D., Narasimhan, V., Wang, M., Huang, Y.-K., Visvanathan, K., McCormick, J., Lynch, A. C., Warrier, S., Michael, M., Desai, J., Murray, W., Mitchell, C., Ngan, S., Phillips, W. A., Heriot, A. G., & Ramsay, R. G.
Venue
JCO Precision Oncology
Published
2018-11
Volume
2
Issue
2
Pages
1-15
ISSN
2473-4284 (ISSN-L)
OpenAlex
W2900172656
Cited by
96
References
8
FWCI
1.94
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Tumor-Infiltrating Lymphocyte Function Predicts Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer. https://app.cochat.ai/papers/10.1200/po.18.00075
The paper
Kong, J. C. H., Guerra, G. R., Millen, R. M., Roth, S., Xu, H., Neeson, P. J., Darcy, P. K., Kershaw, M. H., Sampurno, S., Malaterre, J., Liu, D. S. H., Pham, T. D., Narasimhan, V., Wang, M., Huang, Y.-K., Visvanathan, K., McCormick, J., Lynch, A. C., Warrier, S., . . . Ramsay, R. G. (2018). Tumor-Infiltrating Lymphocyte Function Predicts Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer. JCO Precision Oncology. https://doi.org/10.1200/po.18.00075

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.